Article
Differential effects of PD-1 and PD-L1 immune checkpoint inhibition on cognition and anxiety-like behavior through γδT cells and tumor–dependent neuroinflammation
2026-06-03
Abstract excerpt
<title>Abstract</title> <p>Cancer-related cognitive impairment (CRCI) is increasingly recognized in patients with solid tumors and treated with immunotherapy but the mechanisms linking tumor immune status, systemic inflammation and neurocognitive dysfunction remain unclear. Here, we investigate in syngeneic immuno-desert (B16F10), immuno-excluded (B16F10 Ova) and immuno-inflamed (MC38) tumor-bearing immunocompete...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3f60b51b-a679-5399-89d7-4c3794409d00
- DOI
- 10.21203/rs.3.rs-9519248/v1
